Skip to main content
Clinical Trials/NCT04885569
NCT04885569
Recruiting
Not Applicable

Feasibility Study of Culturally Adapted Cognitive Behavioral Therapy Based Integrated Motivational Interviewing and Mindfulness Intervention for Substance Use Disorder in Pakistan (CAMIAB)

Pakistan Institute of Living and Learning1 site in 1 country260 target enrollmentDecember 1, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Substance Use Disorder (SUD)
Sponsor
Pakistan Institute of Living and Learning
Enrollment
260
Locations
1
Primary Endpoint
Feasibility measures
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

The study has both quantitative and qualitative components. The aim of study is to:

  1. Culturally adapt and integrate the existing Motivational Interviewing with Cognitive Behavioral Therapy(MICBT) and Mindfulness based Relapse Prevention (MBRP) for people with Substance Use Disorder (SUD) in Pakistan
  2. Test the feasibility and acceptability of the integrated intervention called CAMIAB ('CAMIAB' means success in Urdu) in a randomized control trial (RCT).

Detailed Description

This study aims to culturally adapt the existing Motivational Interviewing with CBT (MICBT) and integrate this with Mindfulness-Based Relapse Prevention (MBRP) intervention for people with SUD and to test the feasibility, and acceptability of the intervention in a randomized control trial (RCT). First phase will be cultural adaptation of intervention through focus groups and individual interviews with key stakeholders . Phase two will be to test integrated MICBT and MBRP on a small group of participants N=12. Third phase will be a feasibility factorial randomized control trial with 260 participants with SUD (n=65). Participants will be recruited from primary care hospitals and drug rehabilitation centers in Karachi, Lahore, Rawalpindi, Hyderabad, and Peshawar Pakistan. Intervention will take place weekly over a period of 12 weeks. The intervention will consist of individual as well as group sessions. Assessments will be completed at baseline, after completion of intervention (12th week) and 24th week post randomization. All assessments will be administered by masked research assistants (RAs), not involved in delivering intervention sessions. The therapists delivering the intervention will be trained and will be provided ongoing supervisions by a senior therapist.

Registry
clinicaltrials.gov
Start Date
December 1, 2023
End Date
June 2025
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Feasibility measures

Time Frame: From baseline to 3rd month (at the end of intervention)

Feasibility will be determined by recruitment rates, adherence rate and retention rates. The criterion for success of feasibility is to recruit \>50% of eligible participants, adherence rate (number of home assignments completed; \> 50%) and retention rate of 70%.

Acceptability measure

Time Frame: From baseline to 3rd month (at the end of intervention)

Acceptability will be determined based on the number of sessions attended by participants and success criterion for intervention acceptability is mean attendance rate of at least 8 sessions.

Secondary Outcomes

  • The Maudsley Addiction Profile(Change in problem scores from Baseline to 3rd Month and 6th month)
  • The Short Warwick-Edinburgh Mental Well-being Scale(Change in scores from baseline to 3rd Month and 6th month)
  • EuroQol-5(Change in scores from baseline to 3rd Month and 6th month)
  • Client service receipt inventory(Changes from baseline to 3rd Month and 6th month)

Study Sites (1)

Loading locations...

Similar Trials